ASP Isotopes' 2025 10-K Reveals $175M Net Loss, $(2.11) EPS Amid Expansion Costs
ASPI sits 15% above its 52-week low of $3.92.
Summary
ASP Isotopes reported a substantial net loss of $175.1 million, or $(2.11) per share, for fiscal year 2025, despite revenue growing to $23.8 million from $4.1 million in 2024. The significant widening of the net loss from $35.1 million in the prior year reflects heavy investment in expansion, operating activities, and restructuring costs. While the company achieved early commercial production milestones and made strategic acquisitions like Renergen and Skyline, these efforts have yet to translate into profitability. Traders will closely watch the company's progress on targeted product shipments by mid-2026 and the planned spin-out of QLE to assess future cash flow and path to profitability.
At the time of this announcement, ASPI was trading at $4.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $560.5M. The 52-week trading range was $3.92 to $14.49. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.